Extract Technology chooses Russell Finex to develop a high-containment aseptic powder sieving machine for screening active pharmaceutical ingredients.
ETLs range of downflow booths provide aseptic, contained environments for the safe handling of pharmaceutical powders. The customer on this occasion requested a complete solution for unloading, transferring and screening active pharmaceutical ingredients. The sieving unit needed to be compact, to allow easy integration into a containment environment, as well as quick and easy to dismantle and clean. Furthermore, the solution required the capacity to sieve fine pharmaceutical powders such as folic acid or silicon dioxide at high throughputs.
Following consultation with Russell Finex, ETLs solution was two downflow containment booths with integrated Russell Compact Sieve® units and Vibrasonic® Deblinding System. The sieve units are installed at the end of the downflow booth process, loaded by an elevated hopper following the contained dispensing and weighing of pharmaceutical powders.
The Russell Compact Sieve® was the ideal solution for this type of installation. These vibratory pharmaceutical screeners are used to guarantee the quality of powders during production, providing accurate, high-capacity screening at less than half the size of traditional screeners. The units are quick and easy to dismantle and clean, ideal for the aseptic requirements of pharmaceutical powder processing. The addition of ultrasonic sieving technology eliminates mesh blockages, allowing good product to flow freely through the mesh.
Contact Russell Finex to discover how their innovative sieving and separation solutions can enhance your production line.
Let’s block ads! (Why?)
SINGAPORE - Media OutReach Newswire - 29 April 2024 - From 26 April to 12…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…
Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year Q1…